X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Press Statements

Chronic wounds represent a significant healthcare challenge globally

Content Team by Content Team
26th June 2024
in Press Statements

Chronic wounds represent a significant healthcare challenge globally, affecting approximately 2.21 per 1000 people. The burden of these wounds is growing due to factors like aging populations and the increasing prevalence of conditions such as diabetes, vascular diseases, and obesity. Pallav Dave, a regulatory compliance analyst based in Kentucky, USA, has conducted an in-depth review, titled “The Challenges of Chronic Wound Care and Management,” which explores the complexities and hurdles in managing chronic wounds effectively.

Chronic wounds are defined as wounds that do not follow the normal healing process and remain open for extended periods. These wounds, which include vascular ulcers, diabetic ulcers, and pressure ulcers, have a significant impact on patients’ quality of life by causing pain, infections, and even death. For instance, diabetic ulcers have a 40% mortality rate five years post-occurrence, and 85% of all amputations are attributed to ulcers, with diabetic ulcers accounting for 75% of all lower limb amputations.

Dave’s review highlights the multi-faceted nature of chronic wound care, emphasizing the need for a comprehensive understanding of the wound healing process, which includes four stages: hemostasis, inflammation, proliferation, and remodeling. Chronic wounds often stall in the inflammation phase, characterized by excess cytokines, proteases, reactive oxygen species (ROS), and senescent cells, which hinder proper healing.

One of the critical factors in chronic wound management is addressing bacterial biofilms, which are present in up to 90% of chronic wounds. These biofilms, formed by bacteria that attach to the wound bed, create a protective membrane that impedes antibiotic treatment and slows tissue repair. Effective management involves understanding and mitigating various factors that impair wound healing, including diabetes, poor nutrition, smoking, local tissue factors, systemic factors like age and obesity, and ensuring proper wound bed preparation.

Dave advocates for a holistic approach to managing chronic wounds, which includes thorough patient and wound assessments to identify underlying issues and comorbidities. This holistic approach should incorporate proper nutrition, glycemic control for diabetic patients, optimizing mobility for patients with pressure ulcers, and using compression therapy for venous ulcers. Furthermore, wound bed preparation using the Tissue Infection/Inflammation Moisture Imbalance Epithelial Edge Advancement (TIME) concept is crucial for optimizing wound healing.

Infection control remains a critical component, and it is recommended to assume all chronic wounds are infected to provide appropriate care. Swabs and biopsies help diagnose infections accurately, and topical antimicrobials are preferred over systemic ones for treating superficial infections, though caution is advised to prevent antimicrobial resistance.

The research underscores the importance of a multidisciplinary approach to chronic wound care. By integrating comprehensive patient assessments, personalized care plans, and advanced wound management techniques, healthcare providers can significantly improve patient outcomes. Dave’s study promotes a standardized approach to wound care, ensuring consistent and effective treatment protocols that can be adapted globally.

The implementation of the TIME framework and the emphasis on proper debridement techniques are particularly noteworthy. These strategies facilitate faster healing and reduce the risk of complications associated with chronic wounds. Additionally, Dave’s research highlights the role of patient education and lifestyle modifications in managing chronic wounds, ensuring patients are active participants in their care.

About the author

Pallav Dave is a regulatory compliance analyst based in Kentucky, USA. With a deep understanding of healthcare regulations and a commitment to improving patient outcomes, Dave has dedicated his career to addressing complex healthcare challenges. His latest research on chronic wound care and management reflects his expertise in identifying critical issues and advocating for comprehensive, multidisciplinary approaches to enhance healthcare delivery. Dave’s insights contribute significantly to the ongoing efforts to mitigate the burden of chronic wounds and improve the quality of life for affected patients worldwide.

Google scholar link: http://ajdhs.com/index.php/journal/article/view/70

Previous Post

Liquid Biopsy in Cancer Diagnostics: Definition and Advantages

Next Post

4% CAGR Till 2030 For Water & Wastewater Treatment Equipment

Related Posts

ACHEMA
Middle East and South Asia

ACHEMA Middle East to Debut in Riyadh in 2026 Trade Show

9th May 2025
Press Statements

APM Steam Highlights Comprehensive HVAC Insulation Services for Biopharmaceutical and Pharmaceutical Facilities

19th April 2025
Americas

Thermo Fisher to acquire Solventum’s Purification & Filtration business for US$4.1bn

4th March 2025
Drug Development

Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

4th March 2025
Drug Development

Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

4th March 2025
Press Statements

Saudi Arabia Poised to Expand Domestic Manufacturing Eco-system as 30,000 Attendees join Inaugural CPHI Middle East

11th December 2024
Next Post
4% CAGR Till 2030 For Water & Wastewater Treatment Equipment

4% CAGR Till 2030 For Water & Wastewater Treatment Equipment

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In